Zydus Lifesciences Ltd. NSE: ZYDUSLIFE | BSE: 532321

Mid-range Performer

Download real time

999.80 13.85 (1.40%)

25.76% Gain from 52W Low

1.1M

NSE+BSE Volume

NSE 09 Oct, 2025 12:10 PM (IST)

Regulatory Approval

Zyuds Life gets Health Canada approval for Liothyronine tablets with a market size of CAD 10.9 mn See details

Zydus Lifesciences Ltd. Earnings/Conference Calls

Zydus Lifesciences Ltd. earnings concalls and investor presentations

Is Cadila Healthcare Ltd. worth buying?

860 Votes:

Buy 81.86%

Sell 9.88%

Hold 8.26%

RESEARCH REPORTS

Buy SEE REPORTS >

Buy SEE REPORTS >